BXRX
Baudax Bio, Inc. Common Stock
BXRX
BXRX
Delisted
BXRX was delisted on the 15th of November, 2023.
31 hedge funds and large institutions have $5.58M invested in Baudax Bio, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
31
Holders Change
–
Holders Change %
0%
% of All Funds
0.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
7
Reduced
4
Closed
10
Calls
$361K
Puts
$17K
Net Calls
+$344K
Net Calls Change
-$450K
Top Buyers
1 |
Morgan Stanley
New York
|
$276K |
2 |
State Street
Boston,
Massachusetts
|
$216K |
3 |
Goldman Sachs
New York
|
$115K |
4 |
Geode Capital Management
Boston,
Massachusetts
|
$406K |
5 |
Citadel Advisors
Miami,
Florida
|
$135K |